{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-137105","form_type":"8-K","ticker":"OACC","cik":"0002029769","company_name":"Oaktree Acquisition Corp. III Life Sciences","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.708054+00:00","generated_at":"2026-05-19T18:50:37.871264+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oaktree Acquisition Corp. III Life Sciences CFO resigns; Thomas Sweeney appointed CFO","bullets":["Courtney Conigliaro resigned as CFO effective June 3, 2025; resignation not due to any disagreements.","Board appointed Thomas Sweeney as CFO (principal accounting/financial officer) effective June 3, 2025.","Sweeney is a Managing Director at Oaktree Capital Management; will not receive compensation from the company.","Board confirmed Alvin Shih as chair of the audit committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-137105","json":"https://secwatch.observer/filing/0001193125-25-137105.json","markdown":"https://secwatch.observer/filing/0001193125-25-137105.md","text":"https://secwatch.observer/filing/0001193125-25-137105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/0001193125-25-137105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/d61441d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:50:37.871264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1024533d91","claim":"Courtney Conigliaro resigned as Chief Financial Officer at Oaktree Acquisition Corp. III Life Sciences.","evidence_excerpt":"On June 3, 2025, Courtney Conigliaro notified the board of directors (the \"Board\") of Oaktree Acquisition Corp. III Life Sciences (the \"Company\") of her resignation as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/0001193125-25-137105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"64a1579e06","claim":"Thomas Sweeney was appointed as Chief Financial Officer at Oaktree Acquisition Corp. III Life Sciences.","evidence_excerpt":"On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/0001193125-25-137105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}